AJP Textbook of Clinical Psychiatry British Journal of Psychiatry
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Citation Map
Similar articles found in:
AJP Online
PubMed
PubMed Citation
This Article has been cited by:
other online articles
Search PubMed for articles by:
Amsterdam, J. D. || Beasley, C. M.
Alert me when:
new articles cite this article
Download to Citation Manager
Collections under which this article appears:
Bipolar Disorder
Depression
Antidepressants

Am J Psychiatry 1997; 154:963-969
Copyright 1997 by American Psychiatric Association


SPECIAL ARTICLES

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study

JD Amsterdam, J Fawcett, FM Quitkin, FW Reimherr, JF Rosenbaum, D Michelson, M Hornig-Rohan and CM Beasley
Depression Research Unit, University of Pennsylvania Medical Center, Philadelphia, USA.

OBJECTIVE: Prior studies examining the relationship between fluoxetine plasma concentrations and response in major depression have either found no relationship between plasma concentration and response or suggested a curvilinear relationship with a therapeutic window. To elucidate this relationship, plasma concentrations of fluoxetine, norfluoxetine, fluoxetine plus norfluoxetine, and fluoxetine/norfluoxetine ratio were compared to therapeutic response. METHOD: A total of 839 patients (577 women, 262 men; mean age = 40 [SD = 11] with a DSM-III-R diagnosis of major affective disorder who were in the course of either depression or bipolar disorder not otherwise specified and had a minimum baseline score of 16 on the 17-item Hamilton Depression Rating Scale were initially treated. Response was defined as follows: 1) nonresponders had less that a 50% or more reduction from baseline Hamilton depression score, 2) nonremitting responders had a 50% or more reduction from baseline Hamilton depression score but a final score higher than 7, and 3) remitters had a final Hamilton Depression score of 7 or lower. Plasma fluoxetine and norfluoxetine concentrations were measured after 8 weeks of fixed-dose treatment of 20 mg/day. RESULTS: Plasma concentration data were available from 615 patients. Plasma concentration were similar in responders, both remitting and nonremitting (N = 411), and nonresponders (N = 204) for fluoxetine concentrations, for norfluoxetine concentrations, as well as for the sum of fluoxetine and norfluoxetine and for the ratio of fluoxetine to norfluoxetine. No apparent relationship was observed between plasma drug concentration and clinical response. CONCLUSION: Plasma concentrations of fluoxetine and norfluoxetine do not appear to be related to clinical outcome and should not be used to make treatment decisions.

This article has been cited by other articles:


Home page
J Clin PharmacolHome page
Y. W. F. Lam, C. L. Alfaro, L. Ereshefsky, and M. Miller
Pharmacokinetic and Pharmacodynamic Interactions of Oral Midazolam with Ketoconazole, Fluoxetine, Fluvoxamine, and Nefazodone
J. Clin. Pharmacol., November 1, 2003; 43(11): 1274 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. W. Stewart, F. M. Quitkin, P. J. McGrath, J. Amsterdam, M. Fava, J. Fawcett, F. Reimherr, J. Rosenbaum, C. Beasley, and P. Roback
Use of Pattern Analysis to Predict Differential Relapse of Remitted Patients With Major Depression During 1 Year of Treatment With Fluoxetine or Placebo
Arch Gen Psychiatry, April 1, 1998; 55(4): 334 - 343.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch (General)Home page
NO RELATIONSHIP BETWEEN PLASMA FLUOXETINE LEVEL AND CLINICAL RESPONSE
Journal Watch (General), July 22, 1997; 1997(722): 4 - 4.
[Full Text]


Home page
Journal Watch PsychiatryHome page
No Relation Between Plasma Fluoxetine and Clinical Response
Journal Watch Psychiatry, September 1, 1997; 1997(901): 18 - 18.
[Full Text]


Home page
Br J PsychiatryHome page
D. MICHELSON, M. FAVA, J. AMSTERDAM, J. APTER, P. LONDBORG, R. TAMURA, and R. G. TEPNER
Interruption of selective serotonin reuptake inhibitor treatment: Double-blind, placebo-controlled trial
Br. J. Psychiatry, April 1, 2000; 176(4): 363 - 368.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
J. A. MATTES
Fluoxetine and Norfluoxetine
Am. J. Psychiatry, November 1, 1998; 155(11): 1626q - 1626.
[Full Text]


Home page
Am. J. PsychiatryHome page
C. Thompson, R. C. Peveler, D. Stephenson, and J. McKendrick
Compliance With Antidepressant Medication in the Treatment of Major Depressive Disorder in Primary Care: A Randomized Comparison of Fluoxetine and a Tricyclic Antidepressant
Am. J. Psychiatry, March 1, 2000; 157(3): 338 - 343.
[Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright 1997 by American Psychiatric Association, Inc..